ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
迈克德莫特国际
0.7032
0.0000
成交量:
- -
成交额:
- -
市值:
1.28亿
市盈率:
-0.03
高:
0.7032
开:
0.7032
低:
0.7032
收:
0.7032
52周最高:
10.99
52周最低:
0.5300
股本:
1.82亿
流通股本:
1.80亿
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-26.9921
每股收益(LYR):
-17.9400
净资产收益率:
-385.36%
总资产收益率:
-1.65%
市净率:
0.24
市盈率(LYR):
-0.04
数据加载中...
总览
公司
新闻资讯
公告
印尼数字经济崛起——电商、网约车、外卖和数字金融
华尔街见闻
·
2023/02/08
天益医疗(301097.SZ)取得欧盟MDR认证证书
智通财经
·
2023/01/12
维力医疗(603309.SH):精密尿袋等产品获得欧盟MDR认证
智通财经
·
2023/01/09
腾盛博药发布最新战略性临床开发进展
美通社
·
2022/12/27
开立医疗(300633.SZ):“胸腹腔内窥镜”等产品获欧盟CE(MDR)认证
智通财经
·
2022/12/19
开立医疗(300633.SZ):“S90 Exp系列超声彩色多普勒诊断系统”已获欧盟CE(MDR)认证
智通财经
·
2022/12/19
腾盛博药在2022年美国感染性疾病周(IDWeek 2022)上公布积极临床数据,以支持当前新型HIV治疗候选药物的持续开发
美通社
·
2022/10/19
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MDR/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDR\",,,,,undefined,":{"symbol":"MDR","market":"US","secType":"STK","nameCN":"迈克德莫特国际","latestPrice":0.7032,"timestamp":1579294800000,"preClose":0.7032,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":179823187,"shares":181824089,"eps":-26.992088,"marketStatus":"停牌","change":0,"latestTime":"02-27 17:37:48 EST","open":0.7032,"high":0.7032,"low":0.7032,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-26.992088,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772240400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":0.7032,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDR\",,,,,undefined,":{"symbol":"MDR","floatShares":179823187,"roa":"-1.65%","roe":"-385.36%","lyrEps":-17.94,"shares":181824089,"dividePrice":0,"high":0.7032,"amplitude":0,"preClose":0.7032,"low":0.7032,"week52Low":0.53,"pbRate":"0.24","week52High":10.99,"institutionHeld":0.2633,"latestPrice":0.7032,"eps":-26.992088,"divideRate":0,"volume":0,"delay":0,"ttmEps":-26.992088,"open":0.7032,"prevYearClose":0.6766},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-04-27","symbol":"MDR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1587960000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-02-24","symbol":"MDR","fiscalQuarterEnding":null,"expectedEps":0.73,"name":null,"time":"盘前","type":"earning","dateTimestamp":1582520400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-11-05","symbol":"MDR","fiscalQuarterEnding":"2019/09","expectedEps":-0.21,"name":null,"time":"","type":"earning","dateTimestamp":1572930000000,"reportTimeType":"","actualEps":0.2},{"date":"2019-07-29","symbol":"MDR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":0.08,"defaultRemindTime":1564430400000,"name":null,"time":"盘后","dateTimestamp":1564372800000,"actualEps":0.29},{"market":"US","date":"2019-04-29","symbol":"MDR","fiscalQuarterEnding":"2019/03","expectedEps":0.09,"name":null,"time":"盘前","type":"earning","dateTimestamp":1556510400000,"reportTimeType":"pre","actualEps":0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2309518551","title":"印尼数字经济崛起——电商、网约车、外卖和数字金融","url":"https://stock-news.laohu8.com/highlight/detail?id=2309518551","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2309518551?lang=zh_cn&edition=fundamental","pubTime":"2023-02-08 19:23","pubTimestamp":1675855432,"startTime":"0","endTime":"0","summary":"中金公司认为,印尼及其数字经济具有长期发展前景,主要受益于当地中产阶级崛起、高速数字化和具有弹性的经济增长能力,预计印尼数字经济规模2026年有望达到1108亿美元,复合年增长率13%。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/ee6c891f-64bb-4673-a927-b1f919ce81dc.jpeg?imageView2/1/w/340/h/340","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/ee6c891f-64bb-4673-a927-b1f919ce81dc.jpeg?imageView2/1/w/340/h/340"],"rights":{"source":"wallstreetcn_api","url":"https://wallstreetcn.com/articles/3681476","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3681476","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_api","symbols":["LU0234572021.USD","LU0234570918.USD","IE00B3S45H60.SGD","BK4553","LU0456855351.SGD","LU0786609619.USD","SG9999017495.SGD","SG9999014914.USD","BK4527","IE00BJJMRY28.SGD","IE00BFSS7M15.SGD","LU0079474960.USD","LU1316542783.SGD","LU2237443549.SGD","IE00B1BXHZ80.USD","MDR","BK4514","BK4579",".IXIC","BK4585","BK4587","LU0889565833.HKD","BK4122","SG9999014906.USD","GRAB","LU0861579265.USD","BK4581","IE00B1XK9C88.USD","SGXZ31699556.SGD","LU0127658192.USD","LU0642271901.SGD","CPI","BK4566","SG9999014898.SGD","LU0109392836.USD","IE00BJJMRX11.SGD","LU0238689110.USD","LU1803068979.SGD","IE00BWXC8680.SGD","LU1914381329.SGD","LU2087621335.USD","SG9999001077.SGD","LU2237443382.USD","BK4507","BK4550","IE0004445015.USD","BK4022","SG9999014880.SGD","BK4533","IE0004445239.USD"],"gpt_icon":0},{"id":"2302858701","title":"天益医疗(301097.SZ)取得欧盟MDR认证证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2302858701","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2302858701?lang=zh_cn&edition=fundamental","pubTime":"2023-01-12 12:01","pubTimestamp":1673496106,"startTime":"0","endTime":"0","summary":"智通财经APP讯,天益医疗(301097.SZ)公告,公司近日收到欧盟医疗器械法规(简称“MDR”)认证证书,相关认证产品为:Extracorporeal Blood Tubing Set(体外循环血路)、Oral/Enteral Syringe(喂食注射器)、Oral/Enteral Syringe with ENFit connector(带 ENFit 接头的喂食注射器)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/860834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","MDR","301097"],"gpt_icon":0},{"id":"2302672670","title":"维力医疗(603309.SH):精密尿袋等产品获得欧盟MDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2302672670","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2302672670?lang=zh_cn&edition=fundamental","pubTime":"2023-01-09 16:19","pubTimestamp":1673252394,"startTime":"0","endTime":"0","summary":"智通财经APP讯,维力医疗(603309.SH)发布公告,公司于近日收到欧盟医疗器械法规(简称“MDR”)认证证书,认证产品:Urine Meter精密尿袋(I类灭菌带测量)、Prefilled syringe with purified water or glycerin solution预灌装注射器(I类灭菌)、Empty syringe空注射器(I类灭菌)、Cap导尿塞(I类灭菌)、Spigot导尿管塞(I类灭菌)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/859011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","603309","MDR"],"gpt_icon":0},{"id":"2294764247","title":"腾盛博药发布最新战略性临床开发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2294764247","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2294764247?lang=zh_cn&edition=fundamental","pubTime":"2022-12-27 20:00","pubTimestamp":1672142400,"startTime":"0","endTime":"0","summary":"9月,腾盛博药宣布了其BRII-296新药1期研究的积极顶线结果。腾盛博药最近收到通知,美国FDA已解除针对公司BRII-732的1期研究的临床试验暂停,以开展BRII-732每周一次较低口服剂量的研究。关于腾盛博药 腾盛博药是一家生物技术公司,致力于针对存在巨大未被满足的患者需求、治疗手段有限,以及给患者带来严重社会耻感的世界最常见的疾病开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/3973804_ZH73804_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["MAC","NRTI","BK1161","PPD","BK4080","BK4181","BK4561","02137","BK4551","BK1574","BK4530","IND","MDR","PK","BK1587","BK4121"],"gpt_icon":0},{"id":"2292821948","title":"开立医疗(300633.SZ):“胸腹腔内窥镜”等产品获欧盟CE(MDR)认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2292821948","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2292821948?lang=zh_cn&edition=fundamental","pubTime":"2022-12-19 20:59","pubTimestamp":1671454783,"startTime":"0","endTime":"0","summary":"智通财经APP讯,开立医疗(300633.SZ)发布公告,公司的胸腹腔内窥镜、医用内窥镜图像处理装置、电子上消化道内窥镜和电子下消化道内窥镜已获欧盟CE(MDR)认证,批准日期为:2022年12月16日,CE证书编号:HZ2027206-1,有效期至:2027年07月29日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/849868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","MDR","300633","BK4585","BK4109","CE"],"gpt_icon":0},{"id":"2292582195","title":"开立医疗(300633.SZ):“S90 Exp系列超声彩色多普勒诊断系统”已获欧盟CE(MDR)认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2292582195","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2292582195?lang=zh_cn&edition=fundamental","pubTime":"2022-12-19 20:56","pubTimestamp":1671454595,"startTime":"0","endTime":"0","summary":"智通财经APP讯,开立医疗(300633.SZ)发布公告,公司的S90 Exp系列超声彩色多普勒诊断系统已获欧盟CE(MDR)认证,批准日期为:2022年12月16日,CE证书编号:HZ 2027206-1,有效期至:2027年07月29日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/849864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CE","300633","BK4585","MDR","BK4109","BK0251"],"gpt_icon":0},{"id":"2276022241","title":"腾盛博药在2022年美国感染性疾病周(IDWeek 2022)上公布积极临床数据,以支持当前新型HIV治疗候选药物的持续开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2276022241","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2276022241?lang=zh_cn&edition=fundamental","pubTime":"2022-10-19 20:00","pubTimestamp":1666180800,"startTime":"0","endTime":"0","summary":"这些发现表明,BRII-732和BRII-778有望成为一种安全、耐受性良好的新型患者治疗方案,有助于减轻患者日常的用药负担,甚至还会改善许多HIV感染者目前面临的社会歧视现象。此外,腾盛博药的3个战略开发合作伙伴在IDWeek 2022上公布的16篇摘要,展示了与腾盛博药共同开发的感染性疾病项目。目前针对HIV的口服治疗方案仅限于终身每日给药,许多HIV感染者认为这种给药方式存在问题,并已严重影响到日常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/3907952_ZH07952_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4181","MDR","BK1587","02137","BK1161","PK","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}